RFICs

WHITE PAPERS AND CASE STUDIES

• PFAS Removal System Proven Effective In Removing Both Long And Short Chain PFAS

  A new system removed all nine PFAS compounds from a municipality's water to non-detect levels in a single pass. Unlike traditional methods, it addresses both long- and short-chain PFAS while generating minimal waste.

• Container Selection For A Highly Sensitive Drug Product: A Success Story

  Learn about the importance of selecting the right container for sensitive drug products and how close collaboration is crucial for avoiding commercialization delays and safety risks to patients.

• Sol-Gel Builds Awareness Of Rare Skin Condition, Generates Leads

  Explore a 60-day HCP Awareness email campaign that surpassed industry benchmarks and generated a substantial number of leads.

• A Streamlined Biopharmaceutical Isolator Solution

  This custom-designed, eight-foot isolator helped a client meet their decontamination needs, maintaining ISO-5 sterile conditions while decreasing turn-around time for filling small batches.

• Delivering Complex Oncology Trials At Scale

  Parexel delivered two complex, global Phase III prostate cancer trials by aligning site selection, logistics, imaging workflows, and RAM regulatory expertise—achieving faster enrollment and on‑time execution.

• Oxygen On Demand: How A Gulf Coast Refinery Overcame High COD Challenges With A Rapid H2O2 Dosing System

  The Gulf Coast Refinery approached USP Technologies (USP) to engineer a bulk H2O2 chemical dosing system sized to meet the plant’s D.O. demand

• Unravelling Immunological Depths: Exploring Oxazolone-Induced Delayed-Type Hypersensitivity Model

  Validating the oxazolone-induced DTH mouse model offers a critical platform for advancing the evaluation of therapeutic candidates for chronic inflammatory diseases, including atopic dermatitis.

• Partnership Driving Superior Enrollment And Speed In Phase III Trial

  Examine the partnership between CRIO and Sitero, including how it underscores the significant impact of technology in optimizing trial performance and accelerating treatment development.

• A Pre-Clinical Study For Diet-Induced Obesity

  Here, we look at the importance of using high-fat diet-induced obesity models to evaluate and compare the efficacy of anti-obesity and anti-diabetic treatments like rimonabant and liraglutide.

• Vaccine Trial Sees >90% eCOA Adherence

  Discover how we addressed vaccine trial challenges and drove remarkable success, achieving over 90% adherence to eCOA, ensuring active engagement from the trial participants, and yielding consistent, reliable trial data.

• Oil & Gas Use Case: Permian Basin, Texas

  Modern electrocoagulation provides a reliable alternative to deep-well disposal. By eliminating bacteria and heavy metals while preserving minerals like lithium, these self-cleaning systems deliver high-quality effluent for reuse, reducing seismic risks and operational costs.

• Designing Protocols For A 40% Emulsifiable Concentrate Of A Systemic Insecticide

  Explore how formulation expertise can help overcome the complex challenges of developing stable, effective, and regulatory-compliant emulsifiable concentrate (EC) formulations for crop protection.